PBI
65
5
RRC
59
-4
MMC
60
6
AIV
70
2
DD
60
4
ITW
62
4
CB
51
3
CMG
67
3
VTR
54
5
GILD
49
2
AMAT
42
6
EXC
56
2
TRV
56
3
PVH
57
5
UPS
51
10
PH
73
3
ROK
47
-8
CAT
62
7
ZTS
49
2
FOXA
59
4
PBI
65
5
RRC
59
-4
MMC
60
6
AIV
70
2
DD
60
4
ITW
62
4
CB
51
3
CMG
67
3
VTR
54
5
GILD
49
2
AMAT
42
6
EXC
56
2
TRV
56
3
PVH
57
5
UPS
51
10
PH
73
3
ROK
47
-8
CAT
62
7
ZTS
49
2
FOXA
59
4
Financhill
Back

Mirum Pharmaceuticals Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
69

MIRM
Mirum Pharmaceuticals

Last Price:
43.78
Seasonality Move:
41.89%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Mirum Pharmaceuticals Price Quote

$43.78
+0.30 (+0.69%)
(Updated: November 22, 2024 at 10:00 AM ET)

Mirum Pharmaceuticals Key Stats

Buy
69
Mirum Pharmaceuticals (MIRM) is a Buy
Day range:
$42.27 - $44.12
52-week range:
$23.14 - $48.89
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.68
P/B ratio:
9%
Volume:
352K
Avg. volume:
364.8K
1-year change:
35.88%
Market cap:
$2.1B
Revenue:
$186.4M
EPS:
$-2.07

How Much Does Mirum Pharmaceuticals Make?

Is Mirum Pharmaceuticals Growing As A Company?

  • What Is Mirum Pharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.89%
  • What Is Mirum Pharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Mirum Pharmaceuticals Stock Price Performance

What Is Mirum Pharmaceuticals 52-Week High & Low?

Mirum Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Mirum Pharmaceuticals?

Is Mirum Pharmaceuticals Cash Flow Positive?

  • What Is MIRM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$1.2M
  • What Is Mirum Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $14.1M
  • What Is Mirum Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$92.8M

Mirum Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    MIRM return on invested capital is -18.16%
  • What Is Mirum Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -15.23%
  • What Is MIRM Return On Equity?
    ROE is a measure of profitability and is -41.13%

Mirum Pharmaceuticals Earnings Date & Stock Price

Mirum Pharmaceuticals Competitors

Mirum Pharmaceuticals Dividend Yield

Mirum Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 33.04%
Revenue: 89.37% 10.23%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 62.55
Upside from Last Price: 43.85%

Major Shareholders

  • How many MIRM shares are owned by institutional investors?
    65.5M MIRM shares are owned by institutional investors
  • How many MIRM shares are owned by insiders?
    415.9K MIRM shares are owned by insiders